Out-licensing

A High Vitality Sacchatomyces Cerevisiae Mutant as an Expression System

The present invention relates to high-proliferative mutants of Hepatitis B virus surface antigen producing Saccharomyces cerevisiae transformant. The plasmid-cured strains have high proliferative ability and can thus be used for expressing heterologous proteins.

Conclusion

We have developed a high vitality Sacchatomyces cerevisiae mutant as an expression system for protein and vaccine production.

Relevance/Opportunity

Please enquire quoting reference no. 13A-881202 regarding licensing or codevelopment partnerships.

Preclinical

TW109400;